Tuesday, 23 January 2018
Older articles »
|FDA's tobacco stance faces test with Philip Morris iQOS device|
Added: 22.01.2018 6:11 | 1 views | 0 comments
In a decision expected to test the Trump administration's approach to tobacco regulation, U.S. health advisers will vote this week on whether to allow Philip Morris International Inc to sell its novel iQOS tobacco device and claim it is less harmful than cigarettes.
|Seafood processor nets FDA warning for lack of hazard plan |
Added: 22.01.2018 5:00 | 1 views | 0 comments
A seafood processor in Indonesia is on notice from the Food and Drug Administration for serious violations of the seafood Hazard Analysis and Critical Control Point (HAACP) regulation. According to the Dec. 29 warning letter recently made public by the FDA, the processor's frozen vacuum packaged tuna were rendered injurious to health as they were prepared, packed or held under insanitary conditions. Officials from the...
|#RespectTheEgg: Panera Bread Wants FDA to Be a Good ‘Egg’|
Added: 19.01.2018 15:04 | 0 views | 0 comments
Promoting 100% real eggs and eggsacting standards, Panera Bread cracks into breakfast
|Taking Aim At Competitors, Panera Asks FDA To Define An 'Egg'|
Added: 19.01.2018 13:44 | 0 views | 0 comments
What makes an egg an egg? It sounds like an existential question, but Panera is insisting that it's a practical matter. In conjunction with the official launch of six new breakfast sandwich recipes featuring an over-easy (runny) egg, Panera has petitioned the FDA to better define eggs.
|FDA warns 2nd company of 'significant violations' in lead tests|
Added: 15.01.2018 3:00 | 1 views | 0 comments
Becton Dickinson & Co. officials say they are treating the FDA's concerns with 'the highest sense of urgency.'
|Zhou sticks with Prema for third F3 season|
Added: 12.01.2018 9:00 | 0 views | 0 comments
Zhou, who has been on the FDA scheme since his karting days, will continue for a third season in the championship, where he joins F3 rookies Marcus Armstrong and Robert Shwartzman in the Prema line-up. The 18-year-old from Shanghai enters the season looking for his maiden F3 win, although he has taken seven podium finishes over his two campaigns to date and placed eighth in last ...
|FDA Advisors Slam Lipocine's Testosterone Pill, Raising Doubts About 'Low T' Drugs|
Added: 11.01.2018 16:52 | 0 views | 0 comments
Investors are fleeing from testosterone drugmaker Lipocine today, but its FDA woes portend bigger challenges for companies developing new versions of the embattled hormone.
Copyright © 2008-2018 gffnews.com - all rights reserved